HB 659 (2019): relative to reporting of internal pharmaceutical costs.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 659 (2019): relative to reporting of internal pharmaceutical costs.” Granite Record, https://graniterecord.org/bill/2019/hb659. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 659 (2019): relative to reporting of internal pharmaceutical costs. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2019/hb659
- Chicago
- Granite Record. “HB 659 (2019): relative to reporting of internal pharmaceutical costs.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2019/hb659.
- BibTeX
@misc{bill-2019-hb659, title = {HB 659 (2019): relative to reporting of internal pharmaceutical costs.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2019/hb659}, note = {Accessed 24 Oct. 2026} }
HB 659 (2019)
relative to reporting of internal pharmaceutical costs.
- Status: Killed
- Term: 2019-2020
- House committee: Commerce and Consumer Affairs
- Subject: Insurance
The Story
It was introduced on January 3, 2019 and referred to the House Commerce and Consumer Affairs committee. The committee held a public hearing on February 19, 2019. The committee held a work session on February 21, 2019. The committee met in executive session on February 21, 2019 to vote on its recommendation. The committee held a work session on March 6, 2019. The committee met in executive session on March 8, 2019 to vote on its recommendation. The committee held a work session on March 8, 2019. The committee voted unanimously, 20–0, to recommend that the House kill it, and the report was placed on the consent calendar. On March 19, 2019 the House voted to kill it on a voice vote.
Sponsors
- Rep. Edward Butler (D - Carr 7) (prime sponsor)
- Rep. William Marsh (D - Carr 8)
- Rep. Jerry Knirk (D - Carr 3)
Hearings and Sessions
- February 19, 2019, 10:45 AM: public hearing, House Commerce and Consumer Affairs, LOB 302
- February 21, 2019, 10:30 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
- February 21, 2019, 2:00 PM: executive session, House Commerce and Consumer Affairs, LOB 302
- March 6, 2019, 2:30 PM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
- March 8, 2019, 9:00 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302-304
- March 8, 2019, 1:30 PM: executive session, House Commerce and Consumer Affairs, LOB 302-304
Votes
- March 19, 2019, House: Inexpedient to Legislate — voice vote, passed
The Docket
- January 3, 2019: Introduced 01/03/2019 and referred to Commerce and Consumer Affairs
- February 19, 2019: Public Hearing: 02/19/2019 10:45 am LOB 302
- February 21, 2019: Subcommittee Work Session: 02/21/2019 10:30 am LOB 302
- February 21, 2019: Executive Session: 02/21/2019 02:00 pm LOB 302
- March 6, 2019: Subcommittee Work Session: 03/06/2019 02:30 pm LOB 302
- March 8, 2019: Executive Session: 03/08/2019 01:30 pm LOB 302-304
- March 8, 2019: Subcommittee Work Session: 03/08/2019 09:00 am LOB 302-304
- March 19, 2019: Committee Report: Inexpedient to Legislate for 03/19/2019 (Vote 20-0; CC)
- March 19, 2019: Inexpedient to Legislate: MA VV 03/19/2019